U.S. market Closed. Opens in 45 minutes

GH | Guardant Health, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue563.95M449.54M373.65M286.73M214.38M90.64M49.84M25.25M
Cost of Revenue227.05M156.32M122.91M92.53M70.72M43.21M31.62M22.12M
Gross Profit336.90M293.21M250.74M194.19M143.66M47.43M18.22M3.12M
Operating Expenses899.41M837.59M661.74M449.14M226.03M140.37M94.84M46.97M
Selling, General & Admin449.82M463.78M398.52M299.28M139.73M89.66M69.27M36.11M
Research & Development365.09M373.81M263.22M149.86M86.29M50.71M25.56M10.86M
Other Operating Expenses-84.50M-112.56M25.18M3.64M88.00K4.70MN/AN/A
Operating Income-562.51M-544.38M-411.00M-254.95M-82.37M-92.94M-76.61M-43.85M
Other Expenses / Income83.75M-109.07M26.53M9.05M12.65M4.70M-6.60M-2.29M
Before Tax Income-478.76M-653.45M-384.47M-245.90M-69.72M-84.22M-83.21M-46.13M
Income Tax Expenses685.00K1.14M300.00K379.00K-1.87M38.00K7.00K6.00K
Net Income-479.45M-654.59M-384.77M-246.28M-67.85M-85.06M-83.22M-46.14M
Interest Expenses2.58M2.58M2.58M4.77M1.18M1.25M2.70M3.02M
Basic Shares Outstanding111.99M102.18M101.31M97.50M90.60M30.40M57.78M70.72M
Diluted Shares Outstanding111.99M102.18M101.31M97.50M90.60M30.40M57.78M70.72M
EBITDA-519.63M-650.87M-381.89M-241.14M-68.54M-82.97M-75.31M-39.42M
EBITDA Margin-92.14%-144.79%-102.21%-84.10%-31.97%-91.54%-151.09%-156.13%
EBIT-476.19M-650.87M-381.89M-241.14M-68.54M-83.77M-80.51M-43.12M
EBIT Margin-84.44%-144.79%-102.21%-84.10%-31.97%-92.43%-161.53%-170.76%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙